APOE4 Alzheimer’s Risk Gene: Impact on Brain and Bone Health

Research published in Advanced Science has identified a biological link between the APOE4 gene, a known risk factor for Alzheimer’s disease, and the deterioration of bone quality in women.

The findings reveal that the APOE4 protein causes bone fragility specifically in females, though this effect is not observed in males.

According to a study published October 16, 2025, these deficits in bone quality occur even when We find no changes to the cortical bone structure.

The Link Between Skeletal and Brain Health

The research indicates that age-related risks for neurodegeneration and bone fragility are coupled. This connection is driven by tissue-level deficits resulting from impaired cellular processes.

These cellular impairments manifest as both brain atrophy and a loss of bone mineral density.

By establishing this connection, the research identifies a new molecular pathway that links the risk of Alzheimer’s disease with skeletal health.

Clinical Implications for Diagnosis and Treatment

The discovery of this molecular pathway may provide new tools for the medical community to better manage patients with the APOE4 gene.

The findings could potentially inform earlier diagnoses of cognitive decline by monitoring related biological markers.

the research may help guide the development of targeted treatments to address bone quality loss specifically for women who carry the APOE4 risk gene.